Wael A. Ismail Madkour

article 2026

Editorial Expression of Concern: Does Cabergoline help in decreasing endometrioma size compared to LHRH agonist? A prospective randomized study

·doi:10.1007/s00404-026-08374-7

article 2015

Prevalence of hyperprolactinemia and thyroid disorders among patients with abnormal uterine bleeding

·doi:10.1016/j.ijgo.2015.05.035

OBJECTIVE: To evaluate the prevalence of hyperprolactinemia and thyroid disorders among patients with abnormal uterine bleeding (AUB) compared with matched controls. METHODS: In 2013-2014, an observational study of women with AUB (group A) …

article 2014

Does Cabergoline help in decreasing endometrioma size compared to LHRH agonist? A prospective randomized study

Archives of gynecology and obstetrics ·doi:10.1007/s00404-014-3242-4

AimThe aim of this study was to compare the efficiency of dopamine agonist, Cabergoline, in decreasing the size of endometrioma, with that of luteinizing hormone releasing hormone (LHRH) agonist, triptorelin acetate.StudyThis was a prospect…

article 2012

SESSION 46: ENDOMETRIOSIS/ENDOMETRIUM: CLINICAL STRATEGIES, EVIDENCED OUTCOMES

·doi:10.1093/humrep/27.s2.45